BE536229A - - Google Patents
Info
- Publication number
- BE536229A BE536229A BE536229DA BE536229A BE 536229 A BE536229 A BE 536229A BE 536229D A BE536229D A BE 536229DA BE 536229 A BE536229 A BE 536229A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- xanthocillin
- product
- compounds
- tyrothricin
- Prior art date
Links
- 239000000047 product Substances 0.000 claims description 24
- YBMVKDUTYAGKEW-WHYMJUELSA-N 4-[(1Z,3Z)-4-(4-hydroxyphenyl)-2,3-diisocyanobuta-1,3-dienyl]phenol Chemical compound C1=CC(O)=CC=C1\C=C(/[N+]#[C-])\C(\[N+]#[C-])=C\C1=CC=C(O)C=C1 YBMVKDUTYAGKEW-WHYMJUELSA-N 0.000 claims description 14
- GSXRBRIWJGAPDU-BBVRJQLQSA-N Tyrothricin Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)=O)CC(C)C)C(C)C)C1=CC=C(O)C=C1 GSXRBRIWJGAPDU-BBVRJQLQSA-N 0.000 claims description 11
- 108010021006 Tyrothricin Proteins 0.000 claims description 10
- 229960003281 tyrothricin Drugs 0.000 claims description 10
- 230000000249 desinfective Effects 0.000 claims description 9
- 239000000645 desinfectant Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 239000011149 active material Substances 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 68
- 239000000243 solution Substances 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 230000000844 anti-bacterial Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010026389 Gramicidin Proteins 0.000 description 2
- 229960004905 Gramicidin Drugs 0.000 description 2
- IUAYMJGZBVDSGL-XNNAEKOYSA-N Gramicidin S Chemical compound C([C@@H]1C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1)C(C)C)=O)CC(C)C)C(C)C)C1=CC=CC=C1 IUAYMJGZBVDSGL-XNNAEKOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 230000003385 bacteriostatic Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 210000004400 Mucous Membrane Anatomy 0.000 description 1
- 240000003670 Sesamum indicum Species 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940077747 antacids containing calcium compounds Drugs 0.000 description 1
- 229940077744 antacids containing magnesium compounds Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000721 bacterilogical Effects 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 229940043430 calcium compounds Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001627 detrimental Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE536229A true BE536229A (nl) |
Family
ID=166990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE536229D BE536229A (nl) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE536229A (nl) |
-
0
- BE BE536229D patent/BE536229A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0078785B1 (fr) | Sels d'acide valproîque, leur préparation et leur utilisation | |
FR2757520A1 (fr) | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent | |
LU83423A1 (fr) | Pneumatique radial pour vehicules tout-terrain | |
CA2146765A1 (fr) | Nouveaux derives du taxane, leur preparation et les compositions pharmaceutiques qui les contiennent | |
BE536229A (nl) | ||
BE466916A (nl) | ||
EP0092287B1 (fr) | Sels d'acétylcystéine, leur préparation et leur utilisation | |
LU85292A1 (fr) | Procede pour la preparation de 1,8-dihydroxy-10-acyl-9-anthrones,en particulier pour une utilisation dans le traitement du psoriasis | |
CA2376025C (fr) | Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme antifongiques | |
WO1992001694A1 (fr) | Nouveaux sels derives de la dialcoylaminoalcoylsulfonyl-26 pristinamycine ii¿b? | |
FR2470765A1 (fr) | Nouveaux sels d'addition d'acides du 4'-(9-acridinyl-amino)methanesulf-m-anisidide, leur procede de production et composition pharmaceutique les contenant | |
BE887220A (fr) | Compositions antitumeurs | |
LU84421A1 (fr) | Sels d'acide ursodesoxycholique,leur preparation et leur utilisation | |
EP4367124A1 (fr) | Procédé de préparation de diosmine et de fraction flavonoïque | |
BE482618A (nl) | ||
CH286676A (fr) | Procédé de préparation de la procäine-pénicilline. | |
CH406194A (fr) | Procédé de préparation de sels stables de diméthylcarboxy-alkylsulfonium | |
BE641473A (nl) | ||
CH394234A (fr) | Procédé de préparation du chlorure de la carnitine | |
BE519389A (nl) | ||
CH320196A (fr) | Procédé de préparation du sel calcique pratiquement pur de la chlortétracycline | |
EP0066934A1 (fr) | Sels de nitrofurantoine, leur préparation et leur utilisation | |
BE445966A (nl) | ||
CH334135A (fr) | Procédé de préparation de sulfate de chlortétracycline pratiquement pur | |
CH394488A (fr) | Procédé de préparation d'antigènes cellulaires |